share_log

《業績》復星醫藥(02196.HK)首季淨利潤6.1億人民幣 倒退38.2%

AASTOCKS ·  Apr 29 12:23

復星醫藥(02196.HK)公布3月止第一季度報告,按中國會計準則,實現營業收入101.57億人民幣(下同),按年下降6.6%。歸屬股東淨利潤6.1億元,倒退38.2%,主要是今年新冠相關產品銷售收入大幅下降,以及併購Cenexi的攤銷及運營虧損;每股收益23分。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment